Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opana IR vs Darvocet for Walking Impairment in Lumbar Spinal Stenosis
NCT00652093Phase 4Terminated
- Sponsor
- University of Rochester
- Start
- Mar 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxymorphone in lumbar spinal stenosis (LSS), sponsored by University of Rochester. Started Mar 2008; status: terminated.
02
Drugs
oxymorphone
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on NCT00652093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652093.